Characterisation of intravenous pharmacokinetics in Göttingen minipig and clearance prediction using established in vitro to in vivo extrapolation methodologies

References

• Achour B, Barber J, Rostami-Hodjegan A. 2011. Cytochrome P450 Pig liver pie: determination of individual cytochrome P450 isoform contents in microsomes from two pig livers using liquid chromatography in conjunction with mass spectrometry. Drug Metab Dispos. 39(11):2130–2134.
   PubMed Web of Science ®Google Scholar
• Austin RP, Barton P, Cockroft SL, Wenlock MC, Riley RJ. 2002. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab Dispos. 30(12):1497–1503.
   PubMed Web of Science ®Google Scholar
• Austin RP, Barton P, Mohmed S, Riley RJ. 2005. The binding of drugs to hepatocytes and its relationship to physicochemical properties. Drug Metab Dispos. 33(3):419–425.
   PubMed Web of Science ®Google Scholar
• Bode G, Clausing P, Gervais F, Loegsted J, Luft J, Nogues V, Sims J, Steering Group of the RP. 2010. The utility of the minipig as an animal model in regulatory toxicology. J Pharmacol Toxicol Methods. 62(3):196–220.
   PubMed Web of Science ®Google Scholar
• Bollen P, Ellegaard L. 1997. The Gottingen minipig in pharmacology and toxicology. Pharmacol Toxicol. 80( Suppl 2):3–4.
   PubMedGoogle Scholar
• Bollen PJA, Madsen LW, Meyer O, Ritskes-Hoitinga J. 2005. Growth differences of male and female Göttingen minipigs during ad libitum feeding: a pilot study. Lab Anim. 39(1):80–93.
   PubMed Web of Science ®Google Scholar
• Bridges TM, Morrison RD, Byers FW, Luo S, Scott Daniels J. 2014. Use of a novel rapid and resource-efficient cassette dosing approach to determine the pharmacokinetics and CNS distribution of small molecule 7-transmembrane receptor allosteric modulators in rat. Pharmacol Res Perspect. 2(6):e00077.
   PubMedGoogle Scholar
• Buyssens L, De Clerck L, Schelstraete W, Dhaenens M, Deforce D, Ayuso M, Van Ginneken C, Van Cruchten S. 2021. Hepatic cytochrome P450 abundance and activity in the developing and adult Gottingen minipig: pivotal data for PBPK modeling. Front Pharmacol. 12:665644.
   PubMed Web of Science ®Google Scholar
• Cerny MA. 2016. Prevalence of non-cytochrome P450-mediated metabolism in food and drug administration-approved oral and intravenous drugs: 2006–2015. Drug Metab Dispos. 44(8):1246–1252.
   PubMed Web of Science ®Google Scholar
• Dalgaard L. 2015. Comparison of minipig, dog, monkey and human drug metabolism and disposition. J Pharmacol Toxicol Methods. 74:80–92.
   PubMed Web of Science ®Google Scholar
• Ding N, Yamamoto S, Chisaki I, Nakayama M, Matsumoto SI, Hirabayashi H. 2021. Utility of Gottingen minipigs for the prediction of human pharmacokinetic profiles after intravenous drug administration. Drug Metab Pharmacokinet. 41:100408.
   PubMed Web of Science ®Google Scholar
• Forster R, Bode G, Ellegaard L, van der Laan JW. 2010. The RETHINK project on minipigs in the toxicity testing of new medicines and chemicals: conclusions and recommendations. J Pharmacol Toxicol Methods. 62(3):236–242.
   PubMed Web of Science ®Google Scholar
• Francis LJ, Houston JB, Hallifax D. 2021. Impact of plasma protein binding in drug clearance prediction: a data base analysis of published studies and implications for in vitro-in vivo extrapolation. Drug Metab Dispos. 49(3):188–201.
   PubMed Web of Science ®Google Scholar
• Ganderup NC, Harvey W, Mortensen JT, Harrouk W. 2012. The minipig as nonrodent species in toxicology–where are we now? Int J Toxicol. 31(6):507–528.
   PubMed Web of Science ®Google Scholar
• Grime K, Barton P, McGinnity D. 2013. Application of in silico, in vitro and preclinical pharmacokinetic data for the effective and efficient prediction of human pharmacokinetics. Mol Pharm. 10(4):1191–1206.
   PubMed Web of Science ®Google Scholar
• Grime K, Riley RJ. 2006. The impact of in vitro binding on in vitro–in vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactions. Curr Drug Metab. 7(3):251–264.
   PubMed Web of Science ®Google Scholar
• Hallifax D, Foster JA, Houston JB. 2010. Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view. Pharm Res. 27(10):2150–2161.
   PubMed Web of Science ®Google Scholar
• Hallifax D, Houston JB. 2012. Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs. J Pharm Sci. 101(8):2645–2652.
   PubMed Web of Science ®Google Scholar
• Helke KL, Nelson KN, Sargeant AM, Jacob B, McKeag S, Haruna J, Vemireddi V, Greeley M, Brocksmith D, Navratil N, et al. 2016. Pigs in toxicology: breed differences in metabolism and background findings. Toxicol Pathol. 44(4):575–590.
   PubMed Web of Science ®Google Scholar
• Henze LJ, Koehl NJ, O'Shea JP, Kostewicz ES, Holm R, Griffin BT. 2019. The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review. J Pharm Pharmacol. 71(4):581–602.
   PubMed Web of Science ®Google Scholar
• Houston JB. 1994. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol. 47(9):1469–1479.
   PubMed Web of Science ®Google Scholar
• Ito K, Houston JB. 2004. Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes. Pharm Res. 21(5):785–792.
   PubMed Web of Science ®Google Scholar
• Jones HM, Chen Y, Gibson C, Heimbach T, Parrott N, Peters SA, Snoeys J, Upreti VV, Zheng M, Hall SD. 2015. Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective. Clin Pharmacol Ther. 97(3):247–262.
   PubMed Web of Science ®Google Scholar
• Jones HM, Gardner IB, Collard WT, Stanley PJ, Oxley P, Hosea NA, Plowchalk D, Gernhardt S, Lin J, Dickins M, et al. 2011. Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modelling. Clin Pharmacokinet. 50(5):331–347.
   PubMed Web of Science ®Google Scholar
• Jones RS, Leung C, Chang JH, Brown S, Liu N, Yan Z, Kenny JR, Broccatelli F. 2022. Application of empirical scalars to enable early prediction of human hepatic clearance using IVIVE in drug discovery: an evaluation of 173 drugs. Drug Metabo Dispos. 50(8):1053–1063.
   Web of Science ®Google Scholar
• Jones HM, Parrott N, Jorga K, Lave T. 2006. A novel strategy for physiologically based predictions of human pharmacokinetics. Clin Pharmacokinet. 45(5):511–542.
   PubMed Web of Science ®Google Scholar
• Kilford PJ, Gertz M, Houston JB, Galetin A. 2008. Hepatocellular binding of drugs: correction for unbound fraction in hepatocyte incubations using microsomal binding or drug lipophilicity data. Drug Metab Dispos. 36(7):1194–1197.
   PubMed Web of Science ®Google Scholar
• Landqvist C, Middleton B, Jones B, O'Donnell C. 2014. A novel global approach taken by AstraZeneca to monitor primary DMPK assay performance and understand the inter and intra site assay variability. Drug Discov World. 15:59–63.
   Google Scholar
• Lignet F, Sherbetjian E, Kratochwil N, Jones R, Suenderhauf C, Otteneder MB, Singer T, Parrott N. 2016. Characterization of pharmacokinetics in the Gottingen minipig with reference human drugs: an in vitro and in vivo approach. Pharm Res. 33(10):2565–2579.
   PubMed Web of Science ®Google Scholar
• Lin C, Shi J, Moore A, Khetani SR. 2016. Prediction of drug clearance and drug-drug interactions in microscale cultures of human hepatocytes. Drug Metab Dispos. 44(1):127–136.
   PubMed Web of Science ®Google Scholar
• Liu X, Ding X, Deshmukh G, Liederer BM, Hop CE. 2012. Use of the cassette-dosing approach to assess brain penetration in drug discovery. Drug Metab Dispos. 40(5):963–969.
   PubMed Web of Science ®Google Scholar
• Lombardo F, Shalaeva MY, Tupper KA, Gao F. 2001. ElogDoct: a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds. J Med Chem. 44(15):2490–2497.
   PubMed Web of Science ®Google Scholar
• Manitpisitkul P, White RE. 2004. Whatever happened to cassette-dosing pharmacokinetics? Drug Discov Today. 9(15):652–658.
   PubMed Web of Science ®Google Scholar
• McGinnity DF, Collington J, Austin RP, Riley RJ. 2007. Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs. Curr Drug Metab. 8(5):463–479.
   PubMed Web of Science ®Google Scholar
• Miller NA, Reddy MB, Heikkinen AT, Lukacova V, Parrott N. 2019. Physiologically based pharmacokinetic modelling for first-in-human predictions: an updated model building strategy illustrated with challenging industry case studies. Clin Pharmacokinet. 58(6):727–746.
   PubMed Web of Science ®Google Scholar
• Nagilla R, Nord M, McAtee JJ, Jolivette LJ. 2011. Cassette dosing for pharmacokinetic screening in drug discovery: comparison of clearance, volume of distribution, half-life, mean residence time, and oral bioavailability obtained by cassette and discrete dosing in rats. J Pharm Sci. 100(9):3862–3874.
   PubMed Web of Science ®Google Scholar
• Nunoya T, Shibuya K, Saitoh T, Yazawa H, Nakamura K, Baba Y, Hirai T. 2007. Use of miniature pig for biomedical research, with reference to toxicologic studies. J Toxicol Pathol. 20(3):125–132.
   Google Scholar
• Obach RS. 1999. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos. 27(11):1350–1359.
   PubMed Web of Science ®Google Scholar
• Obach RS, Lombardo F, Waters NJ. 2008. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos. 36(7):1385–1405.
   PubMed Web of Science ®Google Scholar
• Pang KS, Rowland M. 1977. Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm. 5(6):625–653.
   PubMedGoogle Scholar
• Patel NJ, Yumibe N, Ruterbories K, Huang N, Burns L, Tan J, White D, Liu J, Brocksmith D, Bouchard G, et al. 2017. Pharmacokinetics of intravenous and oral metformin and r,s-verapamil in Sinclair, Hanford, Yucatan and Göttingen minipigs. Int J Pharmacokinet. 2(2):81–91.
   Google Scholar
• Poulin P. 2013. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs. J Pharm Sci. 102(7):2085–2095.
   PubMed Web of Science ®Google Scholar
• Poulin P, Collet SH, Atrux-Tallau N, Linget JM, Hennequin L, Wilson CE. 2019. Application of the tissue composition-based model to minipig for predicting the volume of distribution at steady state and dermis-to-plasma partition coefficients of drugs used in the physiologically based pharmacokinetics model in dermatology. J Pharm Sci. 108(1):603–619.
   PubMed Web of Science ®Google Scholar
• Riley RJ, McGinnity DF, Austin RP. 2005. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes. Drug Metab Dispos. 33(9):1304–1311.
   PubMed Web of Science ®Google Scholar
• Sheiner LB, Beal SL. 1981. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm. 9(4):503–512.
   PubMedGoogle Scholar
• Siefert HM, Domdey-Bette A, Henninger K, Hucke F, Kohlsdorfer C, Stass HH. 1999. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species. J Antimicrob Chemother. 43( Suppl B)):69–76.
   PubMed Web of Science ®Google Scholar
• Simianer H, Kohn F. 2010. Genetic management of the Gottingen minipig population. J Pharmacol Toxicol Methods. 62(3):221–226.
   PubMed Web of Science ®Google Scholar
• Singh VK, Thrall KD, Hauer-Jensen M. 2016. Minipigs as models in drug discovery. Expert Opin Drug Discov. 11(12):1131–1134.
   PubMed Web of Science ®Google Scholar
• Skaanild MT. 2006. Porcine cytochrome P450 and metabolism. Curr Pharm Des. 12(11):1421–1427.
   PubMed Web of Science ®Google Scholar
• Smith NF, Raynaud FI, Workman P. 2007. The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discovery. Mol Cancer Ther. 6(2):428–440.
   PubMed Web of Science ®Google Scholar
• Sohlenius-Sternbeck A-K, Afzelius L, Prusis P, Neelissen J, Hoogstraate J, Johansson J, Floby E, Bengtsson A, Gissberg O, Sternbeck J, et al. 2010. Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds. Xenobiotica. 40(9):637–649.
   PubMed Web of Science ®Google Scholar
• Sohlenius-Sternbeck A-K, Jones C, Ferguson D, Middleton BJ, Projean D, Floby E, Bylund J, Afzelius L. 2012. Practical use of the regression offset approach for the prediction of in vivo intrinsic clearance from hepatocytes. Xenobiotica. 42(9):841–853.
   PubMed Web of Science ®Google Scholar
• Suenderhauf C, Parrott N. 2013. A physiologically based pharmacokinetic model of the minipig: data compilation and model implementation. Pharm Res. 30(1):1–15.
   PubMed Web of Science ®Google Scholar
• Suenderhauf C, Tuffin G, Lorentsen H, Grimm H-P, Flament C, Parrott N. 2014. Pharmacokinetics of paracetamol in Göttingen minipigs: in vivo studies and modeling to elucidate physiological determinants of absorption. Pharm Res. 31(10):2696–2707.
   PubMed Web of Science ®Google Scholar
• Swindle MM, Makin A, Herron AJ, Clubb FJ Jr, Frazier KS. 2012. Swine as models in biomedical research and toxicology testing. Vet Pathol. 49(2):344–356.
   PubMed Web of Science ®Google Scholar
• Tang H, Hussain A, Leal M, Mayersohn M, Fluhler E. 2007. Interspecies prediction of human drug clearance based on scaling data from one or two animal species. Drug Metab Dispos. 35(10):1886–1893.
   PubMed Web of Science ®Google Scholar
• Thorn HA, Lundahl A, Schrickx JA, Dickinson PA, Lennernas H. 2011. Drug metabolism of CYP3A4, CYP2C9 and CYP2D6 substrates in pigs and humans. Eur J Pharm Sci. 43(3):89–98.
   PubMed Web of Science ®Google Scholar
• Unger SH, Chiang GH. 1981. Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity. J Med Chem. 24(3):262–270.
   PubMed Web of Science ®Google Scholar
• Wilkinson DJ, Southall RL, Li M, Wright LM, Corfield LJ, Heeley TA, Bratby B, Mannu R, Johnson SL, Shaw V, et al. 2017. Minipig and human metabolism of aldehyde oxidase substrates: in vitro-in vivo comparisons. AAPS J. 19(4):1163–1174.
   PubMed Web of Science ®Google Scholar
• Williamson B, Harlfinger S, McGinnity DF. 2020. Evaluation of the disconnect between hepatocyte and microsome intrinsic clearance and in vitro in vivo extrapolation performance. Drug Metab Dispos. 48(11):1137–1146.
   PubMed Web of Science ®Google Scholar
• Yesair DW, Callahan M, Remington L, Kensler CJ. 1970. Role of the entero-hepatic cycle of indomethacin on its metabolism, distribution in tissues and its excretion by rats, dogs and monkeys. Biochem Pharmacol. 19(5):1579–1590.
   PubMed Web of Science ®Google Scholar
• Yoshimatsu H, Konno Y, Ishii K, Satsukawa M, Yamashita S. 2016. Usefulness of minipigs for predicting human pharmacokinetics: prediction of distribution volume and plasma clearance. Drug Metab Pharmacokinet. 31(1):73–81.
   PubMed Web of Science ®Google Scholar
• Zhu C, Jiang L, Chen TM, Hwang KK. 2002. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. Eur J Med Chem. 37(5):399–407.
   PubMed Web of Science ®Google Scholar